Mulmit

SUTRO BIOPHARMA, INC.SUTRO BIOPHARMA, INC.

STRO Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31102,484,000-158,367,000-191,000,000-22.49
2024-12-3162,043,000-238,453,000-227,000,000-29.4
2023-12-31153,731,000-89,278,000-107,000,000-1.78
2022-12-3167,772,000-128,943,000-119,204,000-2.35
2021-12-3161,880,000-98,524,000-105,538,000-2.29

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-05Hunter Heidi10,000
2026-06-05Dybbs Michael10,000
2026-06-05Wigginton Jon Marc10,000
2026-06-05Jagpal Sukhi10,000
2026-06-05Lobacki Joseph M10,000
2026-06-05Petree Daniel H10,000
2026-06-05MATSUI CONNIE10,000
2026-06-05PANEK JAMES P10,000
2026-06-02Chow Gregory K.CFO2,500
2026-06-02Chow Gregory K.CFO2,500
2026-03-04Pauling DavidChief Admin. Ofcr. & GC675
2026-03-04Pauling DavidChief Admin. Ofcr. & GC277

8-K events

FiledItems
2026-08-12Results of operations · Regulation FD disclosure · Financial statements and exhibits
2026-06-08Submission of matters to a vote
2026-05-14Results of operations · Financial statements and exhibits
2026-03-23Termination of a material agreement · Results of operations · Financial statements and exhibits
2026-02-10Entry into a material agreement · Regulation FD disclosure · Financial statements and exhibits
2025-12-17Other events
2025-12-03Material modification to rights of security holders · Amendments to charter or bylaws · Other events · Financial statements and exhibits
2025-11-06Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.